A generative AI drug discovery company based out of Vancouver has announced a collaboration with Merck, an American pharmaceutical titan established in 1891. The partnership will see Variational AI leverage its signature Enki platform to design and optimize novel small molecule candidates against two undisclosed targets, according to a statement from the firms. Variational AI […]